Phase II Trial of Carboplatin and Bevacizumab for the Treatment of Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial and Spinal Cord Ependymoma in Adults: A Multi-Center Trial
Phase of Trial: Phase II
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin (Primary)
- Indications Ependymoma
- Focus Therapeutic Use
- 17 Nov 2017 Planned number of patients changed from 46 to 35.
- 23 Oct 2015 Planned primary completion date changed from 1 Mar 2017 to 1 Jul 2018, as reported by ClinicalTrials.gov record.
- 12 Aug 2015 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2017, as reported by ClinicalTrials.gov.